The Valley Desk

Clinical trial reportThe international journal of neuropsychopharmacologyPublished

Safety, tolerability, and preliminary efficacy of seltorexant versus quetiapine extended release as adjunctive therapy in major depressive disorder: a randomized, flexible-dose, 6-month, parallel-group, exploratory study

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Johnson & Johnson, Perelman School of Medicine, Philadelphia VA Medical Center, University of Pennsylvania. Affiliation source

Publication record

Type
Clinical trial report
Venue
The international journal of neuropsychopharmacology
Published
Subject terms
Humans; Triazoles; Pyridines; Pyrimidines; Pyrroles; Antidepressive Agents; Delayed-Action Preparations; Treatment Outcome; Drug Therapy, Combination; Double-Blind Method; Dose-Response Relationship, Drug; Adult
PubMed ID
41795948
PubMed Central ID
PMC13070725
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal